Back to Search Start Over

COVID‐19 and tobacco products use among US adults, 2021 National Health Interview Survey

Authors :
Mohammad Ebrahimi Kalan
Rime Jebai
Wei Li
Prem Gautam
Seyedeh Yasaman Alemohammad
Zeinab Mortazavizadeh
D. Ward Kenneth
Aditya Chakraborty
Ghader Dargahi Abbasabad
Raed Behaleh
Zoran Bursac
Ziyad Ben Taleb
Source :
Health Science Reports, Vol 6, Iss 9, Pp n/a-n/a (2023)
Publication Year :
2023
Publisher :
Wiley, 2023.

Abstract

Abstract Background Smoking and vaping are linked to lung inflammation and lowered immune response. Objective Examine the prevalence of coronavirus disease 2019 (COVID‐19) cases, testing, symptoms, and vaccine uptake, and associations with tobacco product use. Methods Data came from the 2021 National Health Interview Survey. The 2021 Sample Adult component included 29,482 participants with a response rate of 50.9%. We investigated COVID‐19‐related outcomes by tobacco product use status and reported national estimates. Multivariable regression models were performed accounting for demographics (e.g., age, sex, poverty level), serious psychological distress, disability, and chronic health conditions. Results In our regression analyses, odds of self‐reported COVID‐19 infection were significantly lower for combustible tobacco product users (vs. nonusers; adjusted odds ratio [AOR = 0.73; 95% confidence interval [CI] = 0.62–0.85]). Combustible tobacco users also were less likely to report ever testing for COVID‐19 (AOR = 0.88; 95% CI = 0.79–0.98), ever testing positive for COVID‐19 (AOR = 0.66; 95% CI = 0.56–0.77), and ever receiving COVID‐19 vaccine (AOR = 0.58; 95% CI = 0.51–0.66) compared with their nonuser peers. Compared to nonusers, users of any type of tobacco who contracted COVID‐19 had higher odds of losing smell (AOR = 1.36; 95%CI = 1.04–1.77), which was more pronounced among exclusive e‐cigarette users. The odds of receiving vaccine were lower for all current exclusive tobacco product users compared to nonusers (AORs = 0.40 to 0.70). Conclusions Continued monitoring of tobacco product use and its association with respiratory diseases such as COVID‐19 is crucial to inform public health policies and programs. In addition, efforts to promote vaccination, especially among tobacco product users, are warranted.

Details

Language :
English
ISSN :
23988835
Volume :
6
Issue :
9
Database :
Directory of Open Access Journals
Journal :
Health Science Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.01cb8bfbe2447fb9e350f296be4a122
Document Type :
article
Full Text :
https://doi.org/10.1002/hsr2.1542